Riskpilot← Back to searchSign inGet full accessSCANDENTA AS
ASActiveOrg 994322508Torget 14, 6631 BatnfjordsøraManufacture of medical and dental instruments and supplies · NACE 3250Est. 20090 employeeswww.gjemneseiendom.no
Revenue 2024
NOK 217K
-76% vs 2023
EBITDA margin
40.8%
-32% vs 2023
Equity ratio
34.9%
Financial strength
Net profit 2024
NOK -99K
+88% vs 2023
| Revenue | NOK 217K | -76% |
| EBITDA | NOK 89K | -32% |
| Net profit | NOK -99K | +88% |
| Total assets | NOK 2,8M | -10% |
| Equity | NOK 991K | -18% |
| Employees | 0 | — |
Legal name
SCANDENTA AS
Org number
994322508
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
25. juli 2009
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Framstilling/salg av tanntekniske produkter og andre produkter som naturlig faller sammen med dette, herunder deltakelse i andre selskaper.
Address
Torget 14, 6631 Batnfjordsøra
Website
www.gjemneseiendom.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 449 | 1 596 | 1 596 | 1 924 | 2 191 | 2 965 | 2 735 | 2 276 | 2 889 | 2 064 | 2 008 | 1 639 | 2 236 | 2 327 | 899 | 217 |
| Staff expenses | −104 | −771 | −812 | −855 | −963 | −1 039 | −1 293 | −1 280 | −1 473 | −1 598 | −1 227 | −578 | −1 439 | −1 450 | −391 | −2 |
| EBITDA | −52 | 255 | 169 | 350 | 646 | 1 066 | 651 | 263 | 705 | −93 | 237 | 569 | 94 | 251 | 131 | 89 |
| Depreciation & amort. | −33 | −80 | −80 | −105 | −134 | −58 | −121 | −143 | −147 | −108 | −94 | −93 | −93 | −114 | −106 | −44 |
| EBIT | −86 | 175 | 89 | 245 | 512 | 1 008 | 531 | 119 | 558 | −201 | 142 | 476 | 0 | 137 | 25 | 44 |
| Net financials | −18 | −35 | −26 | −21 | 6 | 10 | 12 | 5 | −40 | −114 | −111 | −86 | −75 | −103 | −837 | −143 |
| Profit before tax | −103 | 140 | 63 | 224 | 518 | 1 018 | 543 | 124 | 518 | −315 | 31 | 390 | −75 | 34 | −813 | −99 |
| Tax | −0 | 9 | 18 | 60 | 137 | 267 | 135 | 19 | 116 | −73 | 4 | 83 | −16 | 8 | −21 | −0 |
| Net profit | −103 | 131 | 46 | 164 | 381 | 751 | 408 | 105 | 403 | −242 | 27 | 307 | −58 | 26 | −792 | −99 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 647 | 788 | 692 | 963 | 1 216 | 1 569 | 1 833 | 1 962 | 5 149 | 4 596 | 4 439 | 4 570 | 4 511 | 4 276 | 3 171 | 2 842 |
| Equity | 54 | 185 | 230 | 394 | 275 | 1 026 | 1 434 | 1 539 | 1 941 | 1 700 | 1 727 | 2 034 | 1 975 | 2 002 | 1 210 | 991 |
| Long-term debt | 527 | 467 | 298 | 224 | 0 | 0 | 33 | 39 | 2 778 | 2 591 | 2 450 | 2 341 | 2 185 | 2 051 | 1 902 | 1 842 |
| Short-term debt | 66 | 136 | 163 | 344 | 940 | 543 | 366 | 384 | 430 | 305 | 262 | 194 | 351 | 224 | 60 | 9 |
| Total debt | 593 | 603 | 461 | 568 | 940 | 543 | 399 | 423 | 3 207 | 2 896 | 2 712 | 2 536 | 2 536 | 2 274 | 1 961 | 1 851 |
EBITDA margin
40.8%
This company
15.8%
Market median
+158% vs market
20092024
Equity ratio
34.9%
This company
38.2%
Market median
+9% vs market
20092024
Return on equity
-10.0%
This company
18.4%
Market median
-154% vs market
20092024
Net profit margin
-45.5%
This company
8.1%
Market median
-662% vs market
20092024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20092024
Debt / equity
1.87×
This company
0.62×
Market median
-202% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FB Deputy Member | Deputy Member | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Chairman | 2013 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SCANDENTA AS 
GJEMNES EIENDOM ASBoard members of SCANDENTA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ferenc Balint | Deputy Member | 0 companies |
| Jan Ove Berg | Chairman | 0 companies |
| Nicole Samoray | Chairman | 0 companies |